AlveoGene Analysis: $3M Raised
What is AlveoGene?
Inhaled gene therapy for rare respiratory diseases
Location
Oxford, United Kingdom
Employees
1-10
Founded
2022
Product Features & Capabilities
- Inhaled gene therapy solutions for rare respiratory diseases
Use Cases
Targeting specific rare respiratory diseases with gene therapy; Developing inhalation delivery systems for therapeutic agents; Conducting clinical trials for efficacy and safety; Collaborating with research institutions for innovative solutions; Engaging with healthcare providers for patient access
See something that needs updating? Suggest edits to this profile.